FDA Grants “Breakthrough Device Designation” for Early Cancer Detection Test

The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023.  The program grants a designation to certain medical devices that provide more effective treatment or diagnosis of illnesses and…

Continue Reading

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *